Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCI-196 (colestilan) versus simvastatin in dialysis patients with dyslipidemia
NCT00858637Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Mar 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of colestilan in dyslipidemia, sponsored by Mitsubishi Tanabe Pharma. Started Mar 2009; status: completed.
02
Drugs
colestilan
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00858637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00858637.